Armata Pharmaceuticals, Inc. Common Stock (ARMP)

Cost of Revenue

$1.05M

TTM · Period ending: · USD

ARMP logo

ARMP Cost of Revenue

Latest reported$1.05M
ARMP TTM Cost of Revenue ($0.00 → $1.05M)
High-resolution chart · PNG

ARMP cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Armata Pharmaceuticals, Inc. Common Stock Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
-400,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.